GA
RDY icon

Greenspring Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Greenspring Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Sell
23,976
-3,304
-12% -$44.6K 0.02% 245
2026
Q1 		$378K Buy
27,280
+5,230
+24% +$72.8K 0.02% 203
2025
Q4 		$310K Buy
+22,050
New +$309K 0.02% 214

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Greenspring Advisors's RDY Position: Q2 2026 in Review

Greenspring Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 12% in Q2 2026, selling an estimated $44.6K and leaving 23,976 shares worth $347K. The position accounts for 0.02% of the portfolio, ranked #245.

Greenspring Advisors first reported a position in RDY in Q4 2025 and has held it in 3 quarters since. The position peaked at $378K in Q1 2026. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Greenspring Advisors held 23,976 shares of Dr. Reddy's Laboratories worth $347K as of Q2 2026.
  • Greenspring Advisors sold 3,304 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $44.6K.
  • Dr. Reddy's Laboratories made up 0.02% of Greenspring Advisors's portfolio in Q2 2026, its #245 holding.
  • Greenspring Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Greenspring Advisors's Dr. Reddy's Laboratories position peaked at $378K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Greenspring Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.